Toll-like receptor agonists as third signals for dendritic cell-tumor fusion vaccines-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Toll-like receptor agonists as third signals for dendritic cell-tumor fusion vaccines

Published:2009-11-11 Issue:6 Volume:32 Page:700-707
ISSN:1043-3074
Container-title:Head & Neck
language:en
Short-container-title:Head Neck

Author:

Cho Edward I.,Tan Chunrui,Koski Gary K.,Cohen Peter A.,Shu Suyu,Lee Walter T.

Funder

Lerner Institute Research Program Council

Cleveland Clinic

Triological Society Career Development Award

Flight Attendants Medical Research Institute Young Clinical Scientist Award

Publisher

Wiley

Subject

Otorhinolaryngology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hed.21241/fullpdf

Reference14 articles.

1. Dendritic cells and the control of immunity;Banchereau;Nature,1998

2. Immunogenicity and therapeutic efficacy of dendritic-tumor hybrid cells generated by electrofusion;Hayashi;Clin Immunol,2002

3. Electrofusion of syngeneic dendritic cells and tumor generates potent therapeutic vaccine;Kjaergaard;Cell Immunol,2003

4. Tumor-dendritic cell fusion as a basis for cancer immunotherapy;Lee;Otolaryngol Head Neck Surg,2005

5. Immunogenicity of dendritic-tumor fusion hybrids and their utility in cancer immunotherapy;Shu;Crit Rev Immunol,2007

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TLR agonist rHP-NAP as an Adjuvant of Dendritic Cell-Based Vaccine to Enhance Anti-Melanoma Response;IRAN J IMMUNOL;2020

2. TLR-Induced Murine Dendritic Cell (DC) Activation Requires DC-Intrinsic Complement;The Journal of Immunology;2017-05-24

3. The impact of dendritic cell–tumor fusion cells on cancer vaccines - past progress and future strategies;Immunotherapy;2015-10

4. Can dendritic cells improve whole cancer cell vaccines based on immunogenically killed cancer cells?;OncoImmunology;2015-06

5. Poly(I:C) as cancer vaccine adjuvant: Knocking on the door of medical breakthroughs;Pharmacology & Therapeutics;2015-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3